Tiotropium
Prescription ·Strong evidence ·Reviewed May 2026
A long-acting muscarinic antagonist (LAMA/long-acting anticholinergic) that is a first-line maintenance bronchodilator for COPD and an add-on controller for moderate-to-severe asthma. Provides sustained 24-hour bronchodilation with once-daily dosing. In COPD, tiotropium reduces exacerbations, improves lung function, quality of life, and exercise tolerance. In asthma, it is used as add-on therapy when ICS/LABA combinations are insufficient.
The bottom line
Evidence rating strong. Most-documented uses: first-line maintenance bronchodilator for copd, reduces copd exacerbation frequency, improves fev1 and exercise tolerance in copd. 10 sources indexed (2014–2021), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Competitively and reversibly blocks muscarinic M3 receptors on airway smooth muscle and submucosal glands. Acetylcholine released from parasympathetic vagal nerve endings normally activates M3 receptors, causing bronchoconstriction and mucus secretion. Tiotropium's very slow dissociation from M3 receptors (kinetic selectivity, off-rate half-life of ~35 hours from M3 vs ~4 hours from M2) provides prolonged bronchodilation. This M3 selectivity avoids blocking presynaptic M2 autoreceptors, which would paradoxically increase acetylcholine release.
Dosing & protocol.
Delivered by inhalation. Oral bioavailability is extremely low (2-3%) due to quaternary ammonium structure. Systemic effects are minimal. Peak bronchodilation at 1-3 hours, duration >24 hours. Do not swallow capsules, they are for inhalation via HandiHaler device only.
Full safety detail.
Side effects
- Dry mouth (most common anticholinergic effect)
- Constipation
- Urinary retention
- Pharyngitis and upper respiratory tract infection
- Sinusitis
- Blurred vision (if sprayed into eyes)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Tiotropium in the management of paediatric and adolescent asthma: Systematic reviewNeeds reviewPMIDSunther M, Marchon K, Gupta A · Paediatric respiratory reviews · 2021
Sunther M, Marchon K, Gupta A. Tiotropium in the management of paediatric and adolescent asthma: Systematic review. Paediatric respiratory reviews. 2021
- 2[Efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease: systematic review]Needs reviewPMIDCai HD, Hou J, Lyu YN et al. · Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases · 2017
Cai HD, Hou J, Lyu YN et al.. [Efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease: systematic review]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2017
- 3Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysisNeeds reviewPMIDMiravitlles M, Urrutia G, Mathioudakis AG et al. · Respiratory research · 2017
Miravitlles M, Urrutia G, Mathioudakis AG et al.. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis. Respiratory research. 2017
- 4Tiotropium formulations and safety: a network meta-analysisNeeds reviewPMIDCazzola M, Calzetta L, Rogliani P et al. · Therapeutic advances in drug safety · 2017
Cazzola M, Calzetta L, Rogliani P et al.. Tiotropium formulations and safety: a network meta-analysis. Therapeutic advances in drug safety. 2017
- 5Tiotropium versus placebo for inadequately controlled asthma: a meta-analysisNeeds reviewPMIDTian JW, Chen JW, Chen R et al. · Respiratory care · 2014
Tian JW, Chen JW, Chen R et al.. Tiotropium versus placebo for inadequately controlled asthma: a meta-analysis. Respiratory care. 2014
Reference material
5- 6Tashkin DP et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT). N Engl J Med. 2008.Source linkedPMID
- 7Kerstjens HA et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012.Source linkedPMID
- 8GOLD (Global Initiative for Chronic Obstructive Lung Disease). Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2023.Source linkedPMID
- 9Kesten S, Celli B, Decramer M et al.. Tiotropium HandiHaler in the treatment of COPD: a safety review. International journal of chronic obstructive pulmonary disease. 2009Source linkedPMID
- 10Blair HA. Tiotropium/Olodaterol: A Review in COPD. Drugs. 2019Source linkedPMID
Deep dives & adjacent profiles.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Tiotropium in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.